NCT01396408 2026-03-27
A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
Canadian Cancer Trials Group
Phase 2 Active not recruiting
Canadian Cancer Trials Group
St. Jude Children's Research Hospital
National Cancer Institute (NCI)